✦ LIBER ✦

PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN

✍ Scribed by de Ramirez; A Arellano; U Sbarigia; MJ Taylor; P Martin; G Restovic

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHM12 COST-EFFECTIVENESS OF DASATINIBVS

✍ M Brosa; MJ Taylor; U Staginnus; A Meno Duran; KH Cerri; F Cervantes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN13 Cost-Effectiveness Analysis of Nil

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PSY37 A UK Based Cost-Effectiveness Anal

✍ M. Taylor; S. Mealing; D. Scott; J. Clark; M. McKenna; M. Lebmeier; C. Davis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN14 THE COST AND COST EFFECTIVENESS OF

✍ Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Lital 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN34 BUDGET IMPACT ANALYSIS OF DASATINI

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PSY38 A UK Based Cost-Effectiveness Anal

✍ S. Mealing; M. Taylor; D. Scott; J. Clark; M. Mckenna; M. Lebmeier; I. Gilloteau 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB